Emcure Pharmaceuticals Limited has informed the Exchange about General Updates
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has announced that shareholders approved the re-appointment of three Independent Directors through a Postal Ballot, with results declared on March 24, 2026. Mr. Vijay Keshav Gokhale and Dr. Vidya Rajiv Yeravdekar have been re-appointed for a second term of 5 and 3 years respectively, both effective April 16, 2026. Dr. Shailesh Kripalu Ayyangar has been re-appointed for a second term of 5 years effective June 2, 2026. The company confirmed none of these directors are debarred by SEBI or related to any existing director or key managerial personnel. The postal ballot remote e-voting concluded on March 20, 2026.
This is a routine governance update with no material impact on shareholders — continuity on the board is maintained with all three independent directors returning for another term.